Table 1.
Baseline characteristics of patients with and without microbleeds
Characteristics | Total, n=404 | Without MBs, n=321 | With MBs, n=83 | P Value |
---|---|---|---|---|
Age, yr | 60.2±16.4 | 57.9±17.1 | 69.3±8.7 | <0.001 |
Sex, men | 241 (59.7%) | 180 (56.1%) | 61 (73.5%) | 0.22 |
BMI, kg/m2 | 23.2±4.3 | 23.3±4.5 | 23.2±3.4 | 0.95 |
Systolic BP, mmHg | 130.4±22.2 | 125±18 | 152±21 | <0.001 |
Diastolic BP, mmHg | 70.2±10.8 | 69±11 | 75±10 | <0.001 |
Pulse pressure, mmHg | 60.2±18.6 | 56±15 | 78±20 | <0.001 |
Serum creatinine, mg/dl | 2.66±2.48 | 2.30±2.28 | 4.05±2.74 | <0.001 |
BUN, mg/dl | 34.7±25.7 | 30.4±21.7 | 51.4±32.6 | <0.001 |
eGFR, ml/min per 1.73 m2 | 38.6±31.0 | 43.1±31.9 | 21.1±18.6 | <0.001 |
Proteinuria, g/Cre | 2.86±3.42 | 2.78±3.44 | 3.12±3.30 | 0.44 |
Total protein, g/dl | 6.2±1.0 | 6.2±1.0 | 6.2±0.9 | 0.87 |
Albumin, g/dl | 3.3±0.7 | 3.3±0.7 | 3.3±0.6 | 0.62 |
Total cholesterol, mg/dl | 211.2±78.9 | 214.9±81.4 | 196.9±66.9 | 0.06 |
Triglyceride, mg/dl | 155.5±84.7 | 159.2±85.6 | 141.4±80.0 | 0.09 |
HDL cholesterol, mg/dl | 50.1±16.9 | 50.6±17.0 | 48.2±16.7 | 0.25 |
Non-HDL cholesterol, mg/dl | 161.1±73.8 | 164.3±76.6 | 148.7±60.9 | 0.09 |
CRP, mg/dl | 0.09 (0.03–0.28) | 0.08 (0.03–0.25) | 0.12 (0.06–0.46) | 0.67 |
Hemoglobin, g/dl | 11.8±2.5 | 12.0±2.5 | 10.9±2.1 | <0.001 |
Calcium, mg/dl | 9.47±0.63 | 9.50±0.63 | 9.35±0.62 | 0.05 |
Phosphate, mg/dl | 4.17±1.10 | 4.02±0.92 | 4.72±1.50 | <0.001 |
iPTH, pg/ml | 133.3±193.2 | 111.3±137.0 | 200.5±298.8 | <0.001 |
Smoking behavior | 142 (35.1%) | 108 (33.6%) | 34 (41.0%) | 0.25 |
Presence of diabetes | 166 (41.1%) | 127 (39.6%) | 39 (47.0%) | 0.26 |
Presence of dyslipidemia | 149 (36.9%) | 114 (35.5%) | 35 (42.2%) | 0.31 |
Presence of hypertension | 247 (61.1%) | 174 (43.1%) | 73 (88.0%) | <0.001 |
Anticoagulation and/or antiplatelet therapy | 107 (26.5%) | 77 (19.1%) | 30 (36.1%) | 0.04 |
MB, silent cerebral microbleed; BMI, body mass index; Cre, creatinine; CRP, C-reactive protein; iPTH, intact parathyroid hormone.